LOINC
Version 2.67

LP171388-4BivalirudinActive

Description

LP171388-4   Bivalirudin
Bivalirudin (trade names Angiomax or Angiox) is a specific and reversible direct thrombin inhibitor (DTI). It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. Clinical studies demonstrated bivalirudin can be used to treat patients with stable angina, unstable angina (UA), non-ST segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI) undergoing PCI. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Bivalirudin (Wikipedia)

Basic Part Properties

Name
Bivalirudin
Type
Component
Created On
2012-12-19
Construct for LOINC Short Name
Bivalirudin

LOINC FHIR® API Example - CodeSystem Request Get Info

https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP171388-4

Language Variants Get Info

zh-CNChinese (CHINA)
比伐卢定
Synonyms: 比伐芦定;比伐芦丁;抗凝药
nl-NLDutch (NETHERLANDS)
bivalirudine
it-ITItalian (ITALY)
Bivalirudina
ru-RURussian (RUSSIAN FEDERATION)
Бивалирудин
es-ESSpanish (SPAIN)
Bivalirudina
tr-TRTurkish (TURKEY)
Bivalirudin